๐ Related Subjects:
| Osteoporosis
๐ About
Always check the BNF link here before prescribing.
- ๐ Calcitriol = 1,25-dihydroxycholecalciferol.
- It is the active form of Vitamin D (does not require renal hydroxylation).
โก Mechanism of Action
- โฌ๏ธ Increases intestinal absorption of calcium and phosphate.
- ๐ฆด Promotes bone mineralisation and reduces bone resorption.
- ๐งฌ Suppresses PTH secretion (useful in secondary hyperparathyroidism).
๐ฉบ Indications
- Vitamin D deficiency, especially with renal impairment.
- Renal osteodystrophy (CKD-related bone disease).
- Postmenopausal osteoporosis (specialist use).
๐ Dose Calcitriol (1,25 Dihydroxycholecalciferol)
| Indication |
Details |
| Typical |
250โ1000 nanograms OD ๐ก 1000 nanograms = 0.1 micrograms |
| ๐ด Elderly |
Use lower doses to avoid hypercalcaemia |
| โ ๏ธ Monitoring |
Always individualise dose and monitor calcium/U&E closely |
โ ๏ธ Interactions
- See BNF for full list โ interactions possible with enzyme inducers, diuretics, and calcium/phosphate supplements.
โ ๏ธ Cautions
- Hypercalcaemia (monitor serum calcium regularly).
- Risk of metastatic calcification with prolonged high doses.
- Care in patients with renal stones or vascular calcification.
๐ซ Contraindications
- See BNF โ avoid in persistent hypercalcaemia or severe toxicity risk.
๐ฅ Side Effects
- โฌ๏ธ Hypercalcaemia โ symptoms: nausea, vomiting, confusion, arrhythmias.
- ๐ชจ Nephrocalcinosis, renal stones.
- ๐ก๏ธ Rash, urticaria (rare).
๐ References